TYPE 2 DUANE RETRACTION SYNDROME
\tˈa͡ɪp tˈuː dwˈe͡ɪn ɹɪtɹˈakʃən sˈɪndɹə͡ʊm], \tˈaɪp tˈuː dwˈeɪn ɹɪtɹˈakʃən sˈɪndɹəʊm], \t_ˈaɪ_p t_ˈuː d_w_ˈeɪ_n ɹ_ɪ_t_ɹ_ˈa_k_ʃ_ə_n s_ˈɪ_n_d_ɹ_əʊ_m]\
Sort: Oldest first
-
A syndrome characterized by marked limitation of abduction of the eye, variable limitation of adduction and retraction of the globe, and narrowing of the palpebral fissure on attempted adduction. The condition is caused by aberrant innervation of the lateral rectus by fibers of the oculomotor nerve. There are three subtypes: type 1 (associated with loss of abduction), type 2 (associated with loss of adduction), and type 3 (loss of abduction and adduction). Two loci for Duane retraction syndrome have been located, one at chromosome 8q13 (DURS1) and another at chromosome 2q31 (DURS2). It is usually caused by congenital hypoplasia of the abducens nerve or nucleus, but may rarely represent an acquired syndrome. (Adams et al., Principles of Neurology, 6th ed, p271; Miller et al., Clinical Neuro-Ophthalmology, 4th ed, p691)
By DataStellar Co., Ltd
Word of the day
Procollagen Proline Dioxygenase
- mixed-function oxygenase that catalyzes hydroxylation prolyl-glycyl-containing-peptide, usually in protocollagen, hydroxyprolylglycyl-peptide. The enzyme utilizes molecular oxygen with a concomitant oxidative decarboxylation of 2-oxoglutarate to succinate. EC 1.14.11.2.
Nearby Words
- type 1 duane retraction syndrome
- type 1 gaucher disease
- type 1 neurofibromatosis
- type 1 plasminogen activator inhibitor
- type 1 spinocerebellar ataxia
- Type 2 Duane Retraction Syndrome
- type 2 gaucher disease
- type 2 neurofibromatoses
- type 2 neurofibromatosis
- type 2 plasminogen activator inhibitor
- type 2 spinocerebellar ataxia